Charles Williams
COO & Corporate SecretaryMr. Charles Williams, also known as Chuck, served as Chief Financial Officer of Surrozen, Inc. since November 2020 until November 12, 2025 and serves as Chief Operating Officer since February 1, 2024 and also serves as its Corporate Secretary since February 2023. He joined the Surrozen, Inc. in November 2020. Mr. Williams has experience of biopharmaceutical industry across various leadership positions in strategy, operations, finance and corporate development. From 2013 to November 2020, he served as Head of Corporate Development at Jazz Pharmaceuticals plc. From 2008 to 2013, he served as Director of Corporate and Business Development at MAP Pharmaceuticals, Inc., a biopharmaceutical company acquired by Allergan, Inc. Prior to MAP, Mr. Williams held various roles related to business development, finance and strategic planning at CV Therapeutics, Inc., a biopharmaceutical company acquired by Gilead Sciences, Inc. He started his career in biopharmaceutical consulting and investment banking. Mr. Williams earned a B.A. in economics from Cornell University.
Positions
- Company NameSurrozen, Inc.Stock CodeSRZNPositionCOO & Corporate SecretaryColleagues
- CCCraig C. ParkerCEO, President & Director
- DJDavid J. WoodhouseIndependent Chairman of the Board
- YLYang LiExecutive Vice President of Research
- KCK. Christopher GarciaCo-Founder & Member of Scientific Advisory Board
- RNRoeland NusseCo-Founder & Member of Scientific Advisory Board
- CKCalvin KuoCo-Founder & Member of Scientific Advisor
